King George Medical University, Uttar Pradesh-226003, Dr. Mohammad Kaleem Ahmad, King George Medical University, Uttar Pradesh-226003, Dr. Anoop Kumar Verma, King George Medical University, Uttar Pradesh-226003
Project Overview
Traumatic brain injury (TBI) is a significant public health issue causing mortality and long-term disability, particularly in low- and middle-income countries like India. Survivors experience psychosocial problems, severe disability, and neurodegenerative disease due to various causes such as vehicle accidents, falls, firearms, and sports-related injuries. Molecular biomarkers have gained attention due to their clinical value as diagnostic, prognostic, and predictive tools for treating TBI patients. Circulating microRNA (miRNA) could be a potential novel biomarker for disease diagnosis in TBI patients. MicroRNAs, small non-coding RNAs, have been associated with various diseases, but little research has focused on their roles in TBI. Some miRNAs, such as miR-425-5p, play a significant role in maintaining and regulating physiological function in TBI and could be a good diagnostic and prognostic indicator. However, the available data is inconsistent and depends on other geographical factors. This study aims to conduct a case-control study using plasma samples from 115 patients and 115 healthy participants. Advanced next-generation mi-RNA sequencing will be used to examine the expression of miRNAs in patients with severe TBI, providing a wider quantitative range of expression level changes compared to traditional microarrays. Quantitative real-time-PCR will validate these findings to explore the potential role of miRNAs as a diagnostic and prognostic biomarker for TBI. Predicting the role of miRNAs using bioinformatics tools will aid in the development of new therapeutic agents for TBI patients.
Source
Source
Anusandhan National Research Foundation/Science and Engineering Research Board (SERB), DST 2023-24